Predictive Model for PONV for Patient Received Gynecological Laparoscopic Surgery
Dynamic Predictive Model for Postoperative Nausea and Vomiting for Patient Received Gynecological Laparoscopic Surgery
1 other identifier
observational
659
1 country
1
Brief Summary
This is a prospective study to dynamically predict the risk of PONV in patients undergoing gynecologic laparoscopic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedJune 15, 2023
June 1, 2023
6 months
February 22, 2023
June 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
PONV
The occurrence and severity of PONV is evaluated by Visual Analogue Scale (VAS).
Within 24 hours after surgery
Study Arms (2)
Experimental group
Control group
Interventions
This is a prospective risk prediction model building, thus there is no traditional definition of intervention.
Eligibility Criteria
The female patients with gynecological diseases and requiring gynecological laparoscopic surgery.
You may qualify if:
- All female patients receiving gynecological laparoscopic surgery.
You may not qualify if:
- Patients requiring intraoperative open-surgery, requiring other procedures in addition to gynecological laparoscopy, with severe organ dysfunction, unstable postoperative vital signs or requiring transfer to ICU.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jiang Liulead
Study Sites (1)
Weifang Medical University
Weifang, Shangdong, 261000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 22, 2023
First Posted
March 7, 2023
Study Start
September 1, 2022
Primary Completion
March 1, 2023
Study Completion
October 1, 2023
Last Updated
June 15, 2023
Record last verified: 2023-06